Constitutive activation of ERK1/2 has been implicated in a wide variety of processes in the cancer cell during the regulation of cell mortality, apoptosis, angiogenesis, invasion and metastasis, and cell division cycle (4,23). This evidence concerns the gene MAPK3 and cancer.